Host restriction of oncogenesis of RNA tumor viruses in vivo is associated with several gene loci. One of these genes, the 
The complexity of virus-host interactions in the ultimate production of leukemic disease is well illustrated by the genetic aspects of the host response to murine RNA tumor viruses. Although host response is a multigenic effect, one gene in particular, the Fv-1 locus in mice, determines susceptibility or resistance to exogenous Friend or other murine leukemia virus infections (1) (2) (3) (4) . In vivo, this gene determines the susceptibility of mice to Friend disease and, in vitro, controls the ability of Friend leukemia virus (FLV) to replicate successfully (2, 3, 5) . This gene influences the cell-tocell spread of endogenous virus produced in response to chemical induction in mouse-embryo cells in culture (6, 7) and the spontaneous appearance of endogenous virus in mice (7, 8 ). An understanding, therefore, of the molecular basis for host restriction of this gene would be of major importance in the overall study of the relationship of host cell and viral genes in viral oncogenesis.
Strains of murine leukemia virus exist, termed N-or Btropic, defined by their ability to replicate successfully in either NIH Swiss (N-type) or BALB/c (B-type) strains of mice that differ at the Fv-1 locus (2) (3) (4) (5) . Certain strains (e.g., Rauscher and Moloney leukemia virus) replicate equally well in either cell type and are termed NB-tropic. Both N-and B-tropic strains of Friend virus exist as defined in vivo by Lilly and Steeves (10) , and forms the basis of a system in which host restriction may be studied in vitro. Studies of the antigenicity of these two virus strains suggest that they cannot be distinguished by immunological techniques (10) . This finding has suggested that host restriction by nonpermissive cells is a consequence of an intracellular event. However, no direct evidence is available which would define the step in FLV replication at which restriction occurs.
Experiments to be presented here attempt to define whether differences in adsorption and penetration of virus, steps of replication usually associated with the virus envelope, are involved in restriction of FLV by nonpermissive cells. Since the ratio of virus particle to plaque-forming units (PFU) for FLV is not known, a study of the binding of radiolabeled virus to host cell might measure mainly biologically inert material. Therefore, absorption of virus was studied by means of infectivity titer rather than binding of radiolabeled virions. Furthermore, in order to isolate effects of the virus coat in the study of penetration, we used vesicular stomatitis virus (VSV) virions phenotypically mixed within an envelope containing FLV protein. The results of these studies suggest strongly that host restriction of FLV is due to a limiting intracellular step in viral replication.
MATERIALS AND METHODS
Cells. Primary Swiss (N-type) and BALB/c (B-type) mouse-embryo cells were obtained from Microbiological Associates, Rockville, Md. The cells were used at the second or third passage for all experiments and maintained the in vitro characteristics of restriction described by Pincus et al. (7, 8) . S+L-(sarcoma-positive, leukemia-negative) cells, kindly provided by Dr. Robert Bases, are Swiss 3T3 cells transformed with the Moloney strain of murine sarcoma virus as described by Bassin (11) . All cell lines were maintained in Eagle's minimal essential medium supplemented with 10% fetal-calf serum (Grand Island Biologicals), iglutamine, and penicillin-streptomycin.
Viruses. Friend leukemia virus strains F-S (N-tropic) and F-T (B-tropic) (10) were obtained as spleen extracts of infected mice from Dr. Frank Lilly. Each strain was passaged in susceptible mouse-embryo cell cultures. Infected cell supernatants were harvested and frozen at -85°to provide tissue-culture passage stocks of "N" and "B" virus which were then used for all subsequent experiments. VSV, Indiana serotype, was Since such a preparation of VSV may be essentially freed of particles with VSV-specific coat proteins by heat treatment, we reasoned that the resultant, essentially pure, VSV(MLV) could be used to examine the role of the FLV coat in host restriction.
Preliminary studies showed that VSV replicated equally well on either N or B mouse-embryo cultures; therefore we postulated that VSV(FLV), once virus penetration had occurred, should be able to replicate normally. However, if the FLV envelope proteins were involved in the host-restriction mechanism, then a VSV virion whose envelope was VSV (wild type or ts 45) grown in mouse-embryo cells, was titered for infectivity in the cell lines indicated. Before inoculation, virus was treated with antiserum or heat or both. NME and BME, N-and B-type mouse-embryo cells, respectively. NINME, N-type mouseembryo cells infected with N-FLV. N-or B-type mouse-embryo cells, infected, respectively, with N-FLV or B-FLV were superinfected with ts 45 VSV. The progeny of this double infection were characterized as to thermal stability, neutralization by antiserum, and host range as in Table 3 . Results are expressed as logarithm of infectivity titer remaining on each cell type with or without antiserum or heat treatment.
specified either by N-or B-type FLV might demonstrate reduced titers when assayed on the nonpermissive cell.
In The same extent of neutralization with antiserum made against Indiana serotype VSV was observed on treatment of ts 45 VSV (Exps. I and III). An additional control of our antiserum reagents showed no neutralization of either wildtype or ts 45 VSV with FLV antiserum. These data show that no immunological differences could be observed between the neutralization antigen of wild-type and ts 45 VSV by this antiserum, and that no VSV neutralizing antibodies could be detected in FLV antiserum.
VSV(FLV) should possess the following characteristics: (i) because of the FLV envelope, they should be neutralized by antiserum directed against FLV, (ii) they should demonstrate the host range of FLV, that is, they should show reduced efficiency of plating on either HeLa or L cells, and (iii) their replication in mouse-embryo cells previously infected with FLV should be inhibited due to viral interference (16, 17) .
The progeny of virus produced by superinfection of mouseembryo cells infected with N-FLV were tested for these traits ( (22) , whereas in mice the allele for resistance (nonpermissiveness) to FLV is dominant (1, 7, 8) . Host range of avian viruses is strictly correlated with the serotype of the viral envelope. This is not the case for host restriction of FLV, since no serological differences between the envelope antigens of N-FLV and B-FLV have been demonstrated (9) . Host restriction in chicks is virtually absolute (21, 23) , whereas restriction of FLV is relative (7, 8, 24) . The correlate of this latter fact is the phenomenon of a multiple-hit curve seen on titration of FLV in restrictive cells compared with the single-hit curve seen in permissive cells.
Host restriction in avian cells appears to act at the step of viral penetration of host cells (23, 25, 26 (27) have demonstrated that two glycoproteins are exchanged in formation of phenotypically mixed virions of VSV and simian virus-5. Since MLV appears to contain at least two envelope glycopeptides (28) , it is possible that more than one of the surface proteins is necessary to demonstrate host restriction. Furthermore, it could be argued that VSV mixed virions therefore penetrate cells by a mechanism fundamentally different from that of FLV alone. This conclusion is not supported by our results showing the decreased titer of VSV(FLV) when assayed on mouse-embryo cells infected with FLV. Rather, the viral interference, which presumably reflects interference with penetration of the superinfecting virus, demonstrated by VSV(FLV), implies a similarity of adsorption and uptake with native FLV. These data suggest another interesting fact, that viral interference is associated with the neutralization antigen of the leukemia virus.
The observation that both N-FLV and B-FLV form plaques with a one-hit curve on S+L-cells deserves some comment. Since S +L-cells represent B-tropic Swiss 3T3 cells transformed by Moloney sarcoma virus, one might expect that N-FLV would exhibit a reduced efficiency of plating on this cell line. It is possible that the presence of the Moloney sarcoma virus genome somehow alters the cell to permit normal replication. These data are consistent with two possibilities; either that Moloney sarcoma virus genome provides a direct helper effect for intracellular replication of otherwise restricted FLV, or that in these transformed cells expression of the Fv-1 gene is suppressed. These possibilities are testable, and may allow further exploration of the intracellular step that is limiting in the FLV restriction phenom-
